51˶

CDC Issues Health Advisory; Paxlovid Rebound Rates; More Lawyers for Vaccine Claims

— Health news and commentary from around the Web gathered by 51˶ staff

MedpageToday
Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.

Note that some links may require registration or subscription.

The CDC after multiple states reported cases of high blood lead levels in children consuming recalled cinnamon-containing applesauce products to the FDA.

U.S. have improved, according to the American Lung Association.

The Veterans Health Administration to improve appointment scheduling but has not fully implemented others, according to a Government Accountability Office report.

Among adults with COVID, about 20% taking nirmatrelvir–ritonavir (Paxlovid) versus roughly 2% of those untreated, observational data showed. (Annals of Internal Medicine)

COVID and drug overdoses contributed to the , now a 5.8-year difference favoring women, researchers reported in JAMA Internal Medicine.

HCA Healthcare, the nation's largest for-profit hospital chain, following its 2019 acquisition of North Carolina's Mission Health, according to the state attorney general. (NBC News)

Covidien recalled its McGrath Mac after defective products meant for destruction were stolen and sold.

The federal government is to handle vaccine-related claims. (Newsweek)

Whistleblowers suggested a top neuroscientist that support a major stroke trial. (Science)

Initial data from New York City showed no significant increases in crimes or calls for emergency service in neighborhoods where two were located. (JAMA Network Open)

House Republicans have that affects former President Donald Trump's program to end HIV/AIDS in the U.S. (Politico)

Absent a coherent system for elder care in the U.S., . (New York Times, KFF Health News)

Could hearing aids in older adults? (NPR)

An 8-month-old British girl was following a months-long court battle by her family to take her to Italy for treatment. (USA Today)

  • author['full_name']

    Jennifer Henderson joined 51˶ as an enterprise and investigative writer in Jan. 2021. She has covered the healthcare industry in NYC, life sciences and the business of law, among other areas.